Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats.
Toll-like receptors (TLRs) are pattern recognition receptors that have a unique and essential function in innate immunity. The effect of quercetin on TLR-mediated downstream signaling mechanism and its effect on TLR-mediated MAP kinase and Akt pathways were studied in oxLDL-stimulated hPBMCs using specific inhibitors. The pretreatment of hPBMCs with specific TLR inhibitor, CLI-095, decreased the NF-κB nuclear translocation and TNF-α release by oxLDL. When the cells treated with inhibitor and quercetin together, the inhibition was more effective. The specific inhibitor for p38 MAPK, SB203580, reduced the phosphorylated p38 level and decreased the NF-κB activation and TNF-α release by oxLDL-challenged hPBMCs. This inhibitor showed enhanced inhibition when treated with quercetin together. The inhibitors for ERK1/2, PD98059, and for JNK, SP606125, also showed inhibitory effect on NF-κB activation and TNF-α release by oxLDL-simulated hPBMCs. Quercetin supplementation enhanced the inhibition of nuclear translocation of NF-κB and the release of cytokines. TLR4 inhibition study confirmed the downstream signaling mechanism mediated by NF-κB which is involved in the oxLDL-induced inflammatory response, and quercetin suppresses the cytokine, TNF-α release by modulating TLR-NF-κB signaling pathway. In addition to NF-κB signaling pathway, inflammation induced by oxLDL was also related to the activation of p38MAPK, ERK1/2 and JNK, and Akt pathways, and the protective effect of quercetin may be also related to the inhibition of activation of these pathways. Quercetin significantly downregulated the elevated mRNA expression of TLRs and cytokine TNF-α in HCD-fed atherosclerotic rats in vivo. As quercetin possesses inhibition on both TLR-NF-κB signaling pathway and TLR-mediated MAPK pathway, it is evident that it can be used as a therapeutic agent to ameliorate atherosclerotic inflammation. Since quercetin is the major flavonoid and forms the backbone of many other flavonoids and this study provides strong evidence that it has potent anti-inflammatory effect, quercetin may be a promising agent for the prevention and treatment of atherosclerosis and promote health by reducing harmful vascular inflammation.
Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.
Shobha
S
Bhaskar
Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India. helenabiochem@gmail.com.
A
A
Helen
D000818:Animals; D050197:Atherosclerosis / Q000378:metabolism* / Q000473:pathology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism* / Q000473:pathology; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D007963:Leukocytes, Mononuclear / Q000378:metabolism* / Q000473:pathology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D016328:NF-kappa B / Q000378:metabolism; D011794:Quercetin / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D051197:Toll-Like Receptor 4 / Q000378:metabolism*
D008077:Lipoproteins, LDL; D016328:NF-kappa B; C495345:TLR4 protein, human; C495347:Tlr4 protein, rat; D051197:Toll-Like Receptor 4; C099252:oxidized low density lipoprotein; D011794:Quercetin; D048049:Extracellular Signal-Regulated MAP Kinases
Atherosclerosis; Cytokines; Inflammation; MAPK; NF-κB; TLR
Genes Dev. 1995 Jul 1;9(13):1586-97
7628694
Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):733-40
18827577
Curr Biol. 1999 Jun 3;9(11):601-4
10359702
Nutrition. 2013 Jan;29(1):219-29
22595451
Biochem Pharmacol. 2001 Oct 1;62(7):963-74
11543732
J Immunol. 2011 Jul 15;187(2):635-43
21697459
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):253-62
16198162
J Immunol. 2003 Aug 15;171(4):1630-5
12902458
J Immunol. 1996 Jun 15;156(12):4867-75
8648136
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4171-5
1851997
Mol Cancer. 2004 Mar 11;3:7
15016316
J Biol Chem. 2002 Aug 16;277(33):29674-80
12052823
Annu Rev Cell Dev Biol. 2006;22:409-37
16822173
Atherosclerosis. 2004 Oct;176(2):233-45
15380445
Eur J Pharmacol. 2004 Aug 2;496(1-3):41-8
15288573
Br J Pharmacol. 2001 Apr;132(7):1531-41
11264247
Heart Vessels. 2007 Nov;22(6):416-22
18044001
J Lipid Res. 2003 Sep;44(9):1667-75
12810818
Mini Rev Med Chem. 2006 Aug;6(8):945-51
16918500
EMBO J. 1993 Oct;12(10):3879-91
8404856
J Nutr. 2005 Jun;135(6):1359-65
15930438
Science. 1991 Oct 11;254(5029):274-7
1833819
Allergy. 2006 Mar;61(3):289-97
16436136
J Biol Chem. 1994 Feb 18;269(7):5241-8
8106507
Am J Clin Nutr. 2010 Dec;92(6):1511-21
20943792
Indian J Biochem Biophys. 1984 Apr;21(2):130-2
6490072
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):429-34
9892650
Cell Cycle. 2007 Mar 1;6(5):528-33
17351337
Fundam Clin Pharmacol. 2011 Oct;25(5):572-9
21077940
Cell Signal. 2001 Feb;13(2):85-94
11257452
J Rheumatol. 1997 Sep;24(9):1680-4
9292787
Biochem Pharmacol. 2004 Feb 15;67(4):777-85
14757178
J Neurosci. 1998 Mar 1;18(5):1633-41
9464988
Arch Biochem Biophys. 1981 Feb;206(2):271-6
7224637
Annu Rev Immunol. 2002;20:55-72
11861597
Cell Signal. 2005 Aug;17 (8):975-84
15894170
Cardiovasc Res. 2010 Mar 1;85(4):845-52
19910444
Nat Rev Immunol. 2004 Jul;4(7):499-511
15229469
Diabetes. 2005 Jan;54(1):85-91
15616014
Anal Biochem. 1979 Jun;95(2):351-8
36810
Atherosclerosis. 2005 May;180(1):11-7
15823270
Science. 1998 Jan 30;279(5351):710-4
9445477
Immunobiology. 2011 Mar;216(3):367-73
20828867
Circulation. 2002 Oct 8;106(15):1985-90
12370224
Ann Ist Super Sanita. 2007;43(4):394-405
18209273
Mol Cell. 2000 Oct;6(4):909-19
11090628
Immunology. 2005 Jul;115(3):366-74
15946254
J Agric Food Chem. 2009 Mar 11;57(5):2079-86
19196000
J Biol Chem. 2001 Jun 1;276(22):18934-40
11259436
J Clin Invest. 1955 Sep;34(9):1345-53
13252080
Nat Rev Drug Discov. 2004 Jan;3(1):17-26
14708018
Am J Physiol. 1999 Nov;277(5 Pt 2):F779-89
10564243
J Nutr. 2007 May;137(5):1208-15
17449583
Cell Metab. 2007 Dec;6(6):446-57
18054314
Int Immunopharmacol. 2010 Aug;10(8):943-50
20546946
Biochem Biophys Res Commun. 1999 Oct 5;263(3):804-9
10512761